Advances in Melanoma Targeted Therapy
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 4119
Special Issue Editor
Interests: drug screening; anti-cancer drug design and discovery; drug target development; small-molecule drug discovery; cancer biology
Special Issue Information
Dear Colleagues,
Despite the advances in melanoma therapy in recent years, there is still a pressing need for novel approaches and targets. The current treatments for melanoma have many limitations, including low response rates, a lack of targeted therapies for “triple-wide type” and NRAS mutant melanoma, and drug resistance, all of which necessitate the discovery of new agents and targets for melanoma.
In this Special Issue, we aim to publish the most recent developments in targeted therapies for melanoma.
We would like to invite you to contribute research and review manuscripts that report on novel molecules (small and large) that are active against melanoma and novel targets.
We look forward to reading your contributions.
Dr. Dmitriy Minond
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- drug discovery
- new targets
- target discovery